Insider · CIK 0001798679
Matsuda Masaru
officer
Files at ARQT (Arcutis Biotherapeutics, Inc.). First filing Nov 5, 2024, latest Mar 4, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 4
$19k bought, $209k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 16Weak | sell 410b5-1 | ARQT Arcutis Biotherapeutics, Inc. | $43k | 3,263 | -2% | - | |
| 20Weak | sell 510b5-1 | ARQT Arcutis Biotherapeutics, Inc. | $106k | 8,338 | -4% | - | |
| 23Weak | buy 2 | ARQT Arcutis Biotherapeutics, Inc. | $19k | 5,657 | +3% | - | |
| 10Weak | sell 410b5-1 | ARQT Arcutis Biotherapeutics, Inc. | $17k | 1,775 | -1% | - | |
| 16Weak | sell 510b5-1 | ARQT Arcutis Biotherapeutics, Inc. | $44k | 5,015 | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Common Stock10b5-1 | +34,000 | $0.00 | $0 | 212,692 | Mar 4, 2025 |
| Mar 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,263 | $13.03 | $43k | 209,429 | Mar 4, 2025 |
| Feb 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +89,000 | $0.00 | $0 | 89,000 | Mar 4, 2025 |
| Feb 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,338 | $12.70 | $106k | 178,692 | Feb 4, 2025 |
| May 31, 2024 | ARQT Arcutis Biotherapeutics, Inc. | POpen-market purchase Common Stock | +4,000 | $1.69 | $6,768 | 185,373 | Dec 3, 2024 |
| Nov 30, 2024 | ARQT Arcutis Biotherapeutics, Inc. | POpen-market purchase Common Stock | +1,657 | $7.11 | $12k | 187,030 | Dec 3, 2024 |
| Nov 18, 2024 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Common Stock10b5-1 | +4,875 | $0.00 | $0 | 183,148 | Nov 19, 2024 |
| Nov 19, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,775 | $9.68 | $17k | 181,373 | Nov 19, 2024 |
| Nov 4, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,015 | $8.68 | $44k | 178,273 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.